Volume 53, Issue 3 pp. 162-166

Common contact sensitizers in the Czech Republic. Patch test results in 12,058 patients with suspected contact dermatitis*

A. Machovcova

Corresponding Author

A. Machovcova

Department of Dermatology, Faculty Hospital Motol, Praha 5,

Alena Machovcova, MD
Department of Dermatology, Faculty Hospital Motol
V Uvalu 84
150 06 Prague 5
Czech Republic
Tel: + 420 2 2443 8752
Fax: + 420 2 2443 8720
e-mail: [email protected]Search for more papers by this author
E. Dastychova

E. Dastychova

Department of Dermatology, Masaryk University, Brno,

Search for more papers by this author
D. Kostalova

D. Kostalova

Department of Dermatology, Charles University, Plzen,

Search for more papers by this author
A. Vojtechovska

A. Vojtechovska

Department of Dermatology, Faculty Hospital, Ostrava,

Search for more papers by this author
J. Reslova

J. Reslova

Department of Dermatology, Masaryk Hospital, Usti nad Labem,

Search for more papers by this author
D. Smejkalova

D. Smejkalova

Department of Dermatology, Ceské Budejovice,

Search for more papers by this author
J. Vaneckova

J. Vaneckova

Department of Dermatology, Faculty Hospital, Hradec Kralove, and

Search for more papers by this author
A. Vocilkova

A. Vocilkova

Department of Dermatology, Praha, Czech Republic

Search for more papers by this author
First published: 26 August 2005
Citations: 39
*

The study was presented as a poster at the 11th Congress of the European Academy of Dermatology and Venereology, 2–6 October 2002, Prague, Czech Republic.

Abstract

The patch test results of 12 058 patients (4416 male and 7642 female) referred to 9 clinics in the Czech Republic between January 1997 and December 2001 were evaluated. Patients were tested with the same series of allergens by using the standardized patch testing method. The current standard tool for diagnosing allergic contact dermatitis (ACD) in the Czech Republic is the Trolab® test panel (Hermal, Reinbeck, Germany) which consists of 23 allergens. Only a few data exists on ACD in the Czech Republic. All patients were tested with the 23 allergen European standard series. Of these patients, 7661 (63.5%) had 1 or more positive reactions. On average, there were 2.8 positive reactions per patient. ACD, according to clinical relevance, was diagnosed in 5339 (69.7%) of these patients. The most frequent allergens were metals (22.9%), especially nickel sulfate (13.8%), and followed by Myroxylon pereirae resin (balsam of Peru) (7.3%), fragrance mix (5.8%), formaldehyde (4.2%) and lanolin alcohol (3.0%). Our results were compared with results from other countries. We conclude that the European standard series is suitable for detection of ACD in the Czech Republic.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.